KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Tax Provisions (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Tax Provisions for 7 consecutive years, with $8.8 million as the latest value for Q4 2025.

  • Quarterly Tax Provisions rose 87.79% to $8.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.1 million through Dec 2025, up 73.19% year-over-year, with the annual reading at $26.1 million for FY2025, 73.19% up from the prior year.
  • Tax Provisions hit $8.8 million in Q4 2025 for GoodRx Holdings, up from $5.0 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $45.8 million in Q4 2021 to a low of -$46.7 million in Q2 2023.
  • Historically, Tax Provisions has averaged $956950.0 across 5 years, with a median of $4.4 million in 2024.
  • Biggest YoY gain for Tax Provisions was 1189.69% in 2021; the steepest drop was 586.95% in 2021.
  • Year by year, Tax Provisions stood at $45.8 million in 2021, then plummeted by 106.06% to -$2.8 million in 2022, then surged by 144.5% to $1.2 million in 2023, then soared by 278.36% to $4.7 million in 2024, then surged by 87.79% to $8.8 million in 2025.
  • Business Quant data shows Tax Provisions for GDRX at $8.8 million in Q4 2025, $5.0 million in Q3 2025, and $6.7 million in Q2 2025.